Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	442,758	267,413	293,942	446,056	548,450	858,749
Market Cap Growth	-9.03%	-9.03%	-34.10%	-18.67%	-36.13%	-11.44%
Enterprise Value	467,406	289,788	324,970	476,056	565,527	878,631
Last Close Price	6260.00	3860.00	4190.00	6350.57	7804.20	12219.61
PE Ratio	33.30	20.39	-	-	-	-
PS Ratio	7.53	4.55	6.89	11.21	15.30	23.11
PB Ratio	6.76	4.08	4.90	6.80	7.58	11.00
P/TBV Ratio	7.33	4.43	5.22	7.36	8.26	11.27
P/FCF Ratio	56.75	34.28	-	-	-	-
P/OCF Ratio	50.05	30.23	-	-	-	34076.71
EV/Sales Ratio	7.95	4.93	7.62	11.96	15.78	23.64
EV/EBITDA Ratio	50.30	31.18	-	21308.58	-	561.53
EV/EBIT Ratio	75.47	46.79	-	-	-	-
EV/FCF Ratio	59.91	37.14	-	-	-	-
Debt / Equity Ratio	0.67	0.67	0.75	0.58	0.46	0.46
Debt / EBITDA Ratio	4.72	4.72	-	1706.78	-	22.80
Debt / FCF Ratio	5.62	5.62	-	-	-	-
Asset Turnover	0.49	0.49	0.37	0.35	0.30	0.30
Inventory Turnover	2.52	2.52	1.93	1.87	1.77	1.83
Quick Ratio	0.83	0.83	0.52	0.53	0.93	0.72
Current Ratio	1.30	1.30	0.96	1.01	1.61	1.14
Return on Equity (ROE)	23.40%	23.40%	-9.41%	-10.84%	-7.89%	-5.13%
Return on Assets (ROA)	3.21%	3.21%	-3.40%	-2.09%	-2.79%	-1.10%
Return on Capital (ROIC)	3.61%	3.61%	-3.75%	-2.27%	-3.01%	-1.18%
Return on Capital Employed (ROCE)	8.10%	8.10%	-	-	-	-
Earnings Yield	2.96%	4.90%	-1.35%	-1.46%	-0.81%	-0.33%
FCF Yield	1.76%	2.92%	-1.17%	-0.60%	-0.38%	-0.19%
Buyback Yield / Dilution	0.66%	0.66%	0.18%	-0.01%	-0.09%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.